Review article · 2015
Cerebrospinal fluid biomarkers for Alzheimerʼs disease: current limitations and recent developments
Current Opinion in Psychiatry, 28(5), 402–409 · Published 3 July 2015 · DOI 10.1097/yco.0000000000000179
In brief
“Cerebrospinal fluid biomarkers for Alzheimerʼs disease: current limitations and recent developments” is a 2015 review article by Henrik Zetterberg, published in Current Opinion in Psychiatry. OpenAlex counts 51 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 51
- Most cited in
- 2017 (8)
- Field-weighted impact
- 0.69
- References
- 72
- Authors
- 1
Abstract
PURPOSE OF REVIEW: To give perspectives on current limitations and recent developments in the field of cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD). RECENT FINDINGS: Three CSF biomarkers for the neuropathological hallmarks of Alzheimer's disease, namely total tau (T-tau), phospho-tau (P-tau) and the 42 amino acid form of amyloid β (Aβ42), reflecting neurodegeneration, neurofibrillary… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Zetterberg, H. (2015). Cerebrospinal fluid biomarkers for Alzheimerʼs disease: current limitations and recent developments. Current Opinion in Psychiatry, 28(5), 402–409. https://doi.org/10.1097/yco.0000000000000179
MLA 9
Zetterberg, Henrik. “Cerebrospinal fluid biomarkers for Alzheimerʼs disease: current limitations and recent developments.” Current Opinion in Psychiatry, vol. 28, no. 5, 2015, pp. 402–409. https://doi.org/10.1097/yco.0000000000000179.
Chicago
Zetterberg, Henrik. 2015. “Cerebrospinal fluid biomarkers for Alzheimerʼs disease: current limitations and recent developments.” Current Opinion in Psychiatry 28 (5): 402–409. https://doi.org/10.1097/yco.0000000000000179.
Harvard
Zetterberg, H. (2015) ‘Cerebrospinal fluid biomarkers for Alzheimerʼs disease: current limitations and recent developments’, Current Opinion in Psychiatry, 28(5), pp. 402–409. doi:10.1097/yco.0000000000000179.
IEEE
H. Zetterberg, “Cerebrospinal fluid biomarkers for Alzheimerʼs disease: current limitations and recent developments,” Current Opinion in Psychiatry, vol. 28, no. 5, pp. 402–409, 2015, doi: 10.1097/yco.0000000000000179.
BibTeX
@article{zetterberg2015cerebrospinal,
title = {{Cerebrospinal fluid biomarkers for Alzheimerʼs disease: current limitations and recent developments}},
author = {Zetterberg, Henrik},
journal = {Current Opinion in Psychiatry},
year = {2015},
volume = {28},
number = {5},
pages = {402--409},
doi = {10.1097/yco.0000000000000179},
url = {https://doi.org/10.1097/yco.0000000000000179}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2016 | 6 | |
| 2017 | 8 | |
| 2018 | 5 | |
| 2019 | 7 | |
| 2020 | 2 | |
| 2021 | 6 | |
| 2022 | 3 | |
| 2023 | 6 | |
| 2025 | 4 | |
| 2026 | 4 |
Its field-weighted citation impact is 0.69: it has been cited 0.69 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Alzheimer's disease
- cerebrospinal fluid biomarkers
- total tau
- phosphorylated tau
- amyloid-beta 42
- neurodegeneration
- neurofibrillary tangles
- amyloid plaques
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Zetterberg, H. (2015). Cerebrospinal fluid biomarkers for Alzheimerʼs disease: current limitations and recent developments. Current Opinion in Psychiatry, 28(5), 402–409. https://doi.org/10.1097/yco.0000000000000179
How many times has this paper been cited?
51 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Henrik Zetterberg.
What is the DOI of this paper?
10.1097/yco.0000000000000179, permanently at https://doi.org/10.1097/yco.0000000000000179. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.